The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.
 
Lynda M McSorley
No Relationships to Disclose
 
Fathiya Al Rahbi
No Relationships to Disclose
 
Mehala Tharmabala
No Relationships to Disclose
 
Denis Evoy
No Relationships to Disclose
 
James G. Geraghty
No Relationships to Disclose
 
Ruth Prichard
No Relationships to Disclose
 
Jane Rothwell
No Relationships to Disclose
 
Damian McCartan
No Relationships to Disclose
 
Enda McDermott
Travel, Accommodations, Expenses - Roche
 
Maccon M. Keane
No Relationships to Disclose
 
John Kennedy
No Relationships to Disclose
 
Seamus O'Reilly
Honoraria - AstraZeneca; Novartis Ireland Ltd.; Pfizer; Roche
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Steve Millen
Employment - Exact Sciences
 
John Crown
Employment - OncoMark
Stock and Other Ownership Interests - OncoMark
Honoraria - Amgen; Boehringer Ingelheim; Eisai; Genomic Health; MSD Oncology; Novartis Ireland Ltd.; Pfizer; Puma Biotechnology; Roche; Seagen; Vertex
Consulting or Advisory Role - Boehringer Ingelheim; Eisai; G1 Therapeutics; G1 Therapeutics; Pfizer; Puma Biotechnology; Roche; Seagen; Vertex
Speakers' Bureau - Eisai; Genomic Health; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - WO2020011770 (A1) - A method of predicting response to treatment in cancer patients
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; MSD; Novartis Ireland Ltd.; Pfizer; Roche
 
Lillian Mary Smyth
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Research Funding - AstraZeneca (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Roche/Genentech
 
Catherine Margaret Kelly
No Relationships to Disclose
 
Cecily Quinn
No Relationships to Disclose
 
Janice Maria Walshe
Honoraria - Pfizer; Roche
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Roche; Roche/Genentech